Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, 2026, the Compensation Committee of Recursion's Board of ...
Axios on MSN

Models that improve on their own are AI's next big thing

AI models that can learn as they go are one of the hot new areas drawing interest from both startups and the leading labs, including Google DeepMind. Why it matters: The move could accelerate AI's ...
IEEE

Robust Vehicle Mass Estimation Using Recursive Least M-Squares Algorithm for Intelligent Vehicles

Abstract: A practical and reliable online vehicle mass estimation scheme is crucial to effectively control an automated and intelligent vehicle. The Recursive Least Squares with Multiple Forgetting ...
Frontiers

High-precision shape reconstruction for optical fiber sensors based on cubic spline interpolation and tangent angle recursion

School of Physics and Optoelectronics, Xiangtan University, Xiangtan, Hunan, China Accurate reconstruction of optical fiber curves has important applications in fields like medicine, aerospace, and ...
Nasdaq

MicroAlgo Inc. Unveils Quantum Information Recursive Optimization (QIRO) Algorithm for Enhanced Combinatorial Optimization Solutions

MicroAlgo Inc. announced its research on the Quantum Information Recursive Optimization (QIRO) algorithm, which aims to address complex combinatorial optimization problems using quantum computing.
The Motley Fool

4 Things You Need to Know if You Buy Recursion Pharmaceuticals Stock Today

Recursion is using AI and machine learning to accelerate drug research and development. The stock has been under pressure amid an uncertain near-term financial outlook. Several clinical updates from ...
GEN

Trans-Atlantic Triumph: AI Drug Pioneers Recursion, Exscientia Combine

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...
Nasdaq

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

SALT LAKE CITY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The business combination of two AI-powered drug discovery and development companies, Recursion (Nasdaq: RXRX) and Exscientia has been completed, with ...